We may earn a commission for purchases made using our links. Please see our disclosure to learn more.

Disclosure: Some links on Diabetes Fixer are affiliate links. If you buy through them we may earn a small commission at no extra cost to you. We only recommend products our team has researched against peer-reviewed evidence. See our Privacy & Affiliate Disclosure.

These three drugs dominate the GLP-1 weight-loss conversation but they’re often confused. Here’s the simple breakdown: Wegovy and Ozempic are the same active drug (semaglutide) at different doses for different FDA-approved uses. Mounjaro is a different drug (tirzepatide) that hits an additional receptor for stronger effect.

Fight Diabetes

At-a-Glance Comparison

FeatureOzempicWegovyMounjaro
Active ingredientSemaglutideSemaglutideTirzepatide
MakerNovo NordiskNovo NordiskEli Lilly
Receptor targetGLP-1GLP-1GLP-1 + GIP
FDA-approved forType 2 diabetesChronic weight managementType 2 diabetes
Max dose2 mg/week2.4 mg/week15 mg/week
Typical A1C reduction1.4 – 1.8%N/A (non-diabetic use)2.0 – 2.5%
Typical weight loss8 – 12 lbs30 – 35 lbs40 – 50 lbs
How takenWeekly injectionWeekly injectionWeekly injection
Approximate retail (monthly)$900 – $1,200$1,300 – $1,400$1,000 – $1,200

Are Ozempic and Wegovy the Same Drug?

Yes, in terms of the active molecule. Both contain semaglutide. The difference is the dose strength and the FDA-approved indication. Ozempic is dosed up to 2 mg/week for type 2 diabetes; Wegovy is dosed up to 2.4 mg/week specifically for chronic weight management in adults with obesity or overweight + comorbidities.

How Does Mounjaro Compare to Wegovy for Weight Loss?

The SURMOUNT-1 trial showed tirzepatide 15 mg producing 20.9% average body weight loss over 72 weeks — substantially more than semaglutide 2.4 mg (Wegovy) which produced 14.9% in the STEP-1 trial. Eli Lilly’s tirzepatide for chronic weight management (branded Zepbound) received FDA approval in late 2023 for the weight-loss indication.

Which Should You Ask About?

  • For type 2 diabetes only: Ozempic or Mounjaro — Mounjaro produces more A1C reduction
  • For weight loss without diabetes: Wegovy or Zepbound — Zepbound produces more weight loss
  • For both diabetes and weight: Mounjaro (or Ozempic, slightly less weight effect)

See our deeper Ozempic vs. Mounjaro head-to-head for more, or our GLP-1 pillar guide for the full class overview.

Sources & Further Reading

How we research: Articles on Diabetes Fixer are written by our editorial team using AI-augmented research workflows. We summarise evidence from peer-reviewed studies and authoritative bodies including the American Diabetes Association, the CDC, the NIH, and Mayo Clinic. Nothing on this site is medical advice. Talk to your licensed physician before changing diet, medication, or exercise routines.

Categorized in: